Uploaded September 2025 | Updated September 2026, 2 weeks ago
Identifying abnormal cells in blood samples or biopsies can be like finding a needle in a haystack — and most tools take a one-size-fits-all approach. Nuclei.io, an AI-based digital pathology framework developed by James Zou, PhD, and Thomas Montine, MD, PhD, is designed to improve workflow and diagnosis in cancer and other diseases. Instead of trying to replace pathologists, it learns from them, adapting to individual workflows and offering personalized assistance in spotting cells linked to disease. The tool also allows pathologists to share their models with colleagues—almost like a social network—making it easier to compare results, collaborate, and build on one another’s expertise. And at its core, it uses a human-in-the-loop process: pathologists remain the decision-makers, but AI guides them to make diagnoses more efficiently and with greater accuracy.
Nuclei.io was selected as a Stanford Medicine Catalyst-awarded project, underscoring its potential to reshape digital pathology and transform how pathologists work. As a Catalyst-awarded project, it is part of a program designed to help promising ideas move beyond the lab. Catalyst provides guidance, resources, and access to Stanford’s clinical ecosystem so innovations like Nuclei.io can be refined, tested, and brought into practice—making an impact for both clinicians and patients.
Read how a customizable AI tool developed at Stanford Medicine helps pathologists identify diseased cells: http://stan.md/3HyONW0
Learn more about Catalyst:: https://smcatalyst.stanford.edu/
INNOVATING HEALTH highlights how Stanford Medicine researchers are addressing urgent challenges in health care and biomedical discovery, showing how new ideas and technologies are improving medicine today and shaping a healthier tomorrow.
#aihealthcare #pathology #healthcareinnovation
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
Identifying abnormal cells in blood samples or biopsies can be like finding a needle in a haystack — and most tools take a one-size-fits-all approach. Nuclei.io, an AI-based digital pathology framework developed by James Zou, PhD, and Thomas Montine, MD, PhD, is designed to improve workflow and diagnosis in cancer and other diseases. Instead of trying to replace pathologists, it learns from them, adapting to individual workflows and offering personalized assistance in spotting cells linked to disease. The tool also allows pathologists to share their models with colleagues—almost like a social network—making it easier to compare results, collaborate, and build on one another’s expertise. And at its core, it uses a human-in-the-loop process: pathologists remain the decision-makers, but AI guides them to make diagnoses more efficiently and with greater accuracy.
Nuclei.io was selected as a Stanford Medicine Catalyst-awarded project, underscoring its potential to reshape digital pathology and transform how pathologists work. As a Catalyst-awarded project, it is part of a program designed to help promising ideas move beyond the lab. Catalyst provides guidance, resources, and access to Stanford’s clinical ecosystem so innovations like Nuclei.io can be refined, tested, and brought into practice—making an impact for both clinicians and patients.
Read how a customizable AI tool developed at Stanford Medicine helps pathologists identify diseased cells: http://stan.md/3HyONW0
Learn more about Catalyst:: https://smcatalyst.stanford.edu/
INNOVATING HEALTH highlights how Stanford Medicine researchers are addressing urgent challenges in health care and biomedical discovery, showing how new ideas and technologies are improving medicine today and shaping a healthier tomorrow.
#aihealthcare #pathology #healthcareinnovation
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
